Tags: Physiology · Bone
Project: r01_doug_adams
2 loci · 2 genes with independent associations · 3 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 1 | 254889979 | 256760534 | 2 | 1 | 1.20e-07 | 3.28e-07 | 1.00e+00 | Afap1l2 |
2 | 5 | 59640609 | 61037099 | 1 | 1 | 6.01e-08 | 6.26e-06 | 1.18e-02 | Tmod1 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.74 |
Adipose | alternative TSS | 0 | 0 | 1.51 |
Adipose | gene expression | 0 | 0 | 1.64 |
Adipose | isoform ratio | 0 | 0 | 1.59 |
Adipose | intron excision ratio | 0 | 0 | 1.69 |
Adipose | mRNA stability | 0 | 0 | 1.66 |
BLA | alternative polyA | 0 | 0 | 1.57 |
BLA | alternative TSS | 0 | 0 | 1.71 |
BLA | gene expression | 0 | 0 | 1.72 |
BLA | isoform ratio | 0 | 0 | 1.63 |
BLA | intron excision ratio | 0 | 0 | 1.59 |
BLA | mRNA stability | 0 | 0 | 1.69 |
Brain | alternative polyA | 0 | 0 | 1.65 |
Brain | alternative TSS | 0 | 0 | 1.69 |
Brain | gene expression | 0 | 0 | 1.65 |
Brain | isoform ratio | 0 | 0 | 1.61 |
Brain | intron excision ratio | 0 | 0 | 1.65 |
Brain | mRNA stability | 0 | 0 | 1.6 |
Eye | alternative polyA | 0 | 0 | 1.71 |
Eye | alternative TSS | 0 | 0 | 1.52 |
Eye | gene expression | 0 | 0 | 1.85 |
Eye | isoform ratio | 0 | 0 | 1.54 |
Eye | intron excision ratio | 0 | 0 | 1.76 |
Eye | mRNA stability | 0 | 0 | 1.58 |
IL | alternative polyA | 0 | 0 | 1.83 |
IL | alternative TSS | 0 | 0 | 1.45 |
IL | gene expression | 0 | 0 | 1.7 |
IL | isoform ratio | 0 | 0 | 1.69 |
IL | intron excision ratio | 0 | 0 | 1.62 |
IL | mRNA stability | 0 | 0 | 1.68 |
LHb | alternative polyA | 0 | 0 | 1.76 |
LHb | alternative TSS | 0 | 0 | 1.62 |
LHb | gene expression | 0 | 0 | 1.7 |
LHb | isoform ratio | 0 | 0 | 1.65 |
LHb | intron excision ratio | 0 | 0 | 1.65 |
LHb | mRNA stability | 0 | 0 | 1.72 |
Liver | alternative polyA | 2 | 0.1 | 1.56 |
Liver | alternative TSS | 0 | 0 | 1.71 |
Liver | gene expression | 0 | 0 | 1.66 |
Liver | isoform ratio | 0 | 0 | 1.56 |
Liver | intron excision ratio | 0 | 0 | 1.71 |
Liver | mRNA stability | 0 | 0 | 1.64 |
NAcc | alternative polyA | 0 | 0 | 1.68 |
NAcc | alternative TSS | 0 | 0 | 1.6 |
NAcc | gene expression | 0 | 0 | 1.68 |
NAcc | isoform ratio | 0 | 0 | 1.61 |
NAcc | intron excision ratio | 0 | 0 | 1.62 |
NAcc | mRNA stability | 0 | 0 | 1.73 |
OFC | alternative polyA | 0 | 0 | 1.85 |
OFC | alternative TSS | 0 | 0 | 1.66 |
OFC | gene expression | 0 | 0 | 1.76 |
OFC | isoform ratio | 0 | 0 | 1.6 |
OFC | intron excision ratio | 0 | 0 | 1.6 |
OFC | mRNA stability | 2 | 0.2 | 1.74 |
PL | alternative polyA | 0 | 0 | 1.73 |
PL | alternative TSS | 0 | 0 | 1.63 |
PL | gene expression | 0 | 0 | 1.71 |
PL | isoform ratio | 0 | 0 | 1.58 |
PL | intron excision ratio | 0 | 0 | 1.61 |
PL | mRNA stability | 0 | 0 | 1.69 |